Jin Long Chen - Oct 11, 2021 Form 4 Insider Report for NGM BIOPHARMACEUTICALS INC (NGM)

Role
Chief Scientific Officer, Director
Signature
/s/ Jin-Long Chen
Stock symbol
NGM
Transactions as of
Oct 11, 2021
Transactions value $
-$608,250
Form type
4
Date filed
10/13/2021, 04:34 PM
Previous filing
Sep 14, 2021
Next filing
Nov 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NGM Common Stock Sale -$306K -15K -1.61% $20.41* 914K Oct 11, 2021 Direct F1, F2
transaction NGM Common Stock Sale -$302K -15K -1.64% $20.14* 899K Oct 12, 2021 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2021.
F2 Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $19.75 to $20.66. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $19.91 to $20.52. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.